RTIvalence of Infection in Pregnant Women FetalNeonatal Transmission Rate Incidence of the Manifestation ithout Interventions verse pregnancy outcomes caused by industrialized countries parts of Sout ID: 889227
Download Pdf The PPT/PDF document "x0000x0000Module 3 Reproductive Tract In..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1 ��M
��M
2 odule 3: Reproduc
odule 3: Reproduc
3 tive Tract Infect
tive Tract Infect
4 ions able 3. Prev
ions able 3. Prev
5 alence, Transmiss
alence, Transmiss
6 ion Rates, and Ma
ion Rates, and Ma
7 nifestations of S
nifestations of S
8 elected RTIs RT
elected RTIs RT
9 I valence of Infe
I valence of Infe
10 ction in Pregnant
ction in Pregnant
11 Women Fetal/Neon
Women Fetal/Neon
12 atal Transmission
atal Transmission
13 Rate Incidence o
Rate Incidence o
14 f the Manifestati
f the Manifestati
15 on ithout Interve
on ithout Interve
16 ntions verse preg
ntions verse preg
17 nancy outcomes ca
nancy outcomes ca
18 used by industria
used by industria
19 lized countries;
lized countries;
20 parts of South Am
parts of South Am
21 erica, and Fiji O
erica, and Fiji O
22 verall, 40%Ã70%;
verall, 40%Ã70%;
23 perhaps as low a
perhaps as low a
24 s 23% At a seropr
s 23% At a seropr
25 evalence of 10%,
evalence of 10%,
26 over 5% of all pr
over 5% of all pr
27 egnant women woul
egnant women woul
28 d have an adverse
d have an adverse
29 outcome: 2% spon
outcome: 2% spon
30 taneous abortions
taneous abortions
31 ; Low: 1% or less
; Low: 1% or less
32 , such as in West
, such as in West
33 ern Europe and so
ern Europe and so
34 me parts of North
me parts of North
35 America in sub-S
America in sub-S
36 aharan Africa Chl
aharan Africa Chl
37 amydia trachomati
amydia trachomati
38 s Chlamydial opht
s Chlamydial opht
39 halmia trachomati
halmia trachomati
40 s Low: 0%Ã5% Tot
s Low: 0%Ã5% Tot
41 al: 60%Ã70% 15%Ã
al: 60%Ã70% 15%Ã
42 30% severe, 25%
30% severe, 25%
43 coming to medical
coming to medical
44 careseroprevalen
careseroprevalen
45 ce, 2.5% of pregn
ce, 2.5% of pregn
46 ancies would resu
ancies would resu
47 lt in who are bro
lt in who are bro
48 ught to medical c
ught to medical c
49 are. Chlamydia
are. Chlamydia
50 l pneumonia; Chla
l pneumonia; Chla
51 mydia trachomatis
mydia trachomatis
52 Low: 0%Ã5% Pneu
Low: 0%Ã5% Pneu
53 monia: 5%Ã15%; 5
monia: 5%Ã15%; 5
54 % coming to medic
% coming to medic
55 al care seropreva
al care seropreva
56 lence, 0.5% of pr
lence, 0.5% of pr
57 egnancies would r
egnancies would r
58 esult in infants
esult in infants
59 with 20%Ã50% in
with 20%Ã50% in
60 the United States
the United States
61 have developed a
have developed a
62 ntibodies to HSV;
ntibodies to HSV;
63 viral excretion a
viral excretion a
64 t delivery is app
t delivery is app
65 roximately 0.01%Ã
roximately 0.01%Ã
66 0.39%; prevalen
0.39%; prevalen
67 ce appears lower
ce appears lower
68 in other parts of
in other parts of
69 Primary infectio
Primary infectio
70 n: 50% Recurrent
n: 50% Recurrent
71 infection: Incide
infection: Incide
72 nce is 0.2%Ã0.33
nce is 0.2%Ã0.33
73 % per 1,000 live
% per 1,000 live
74 births in the Uni
births in the Uni
75 ted States, with
ted States, with
76 overall Industria
overall Industria
77 lized countries:
lized countries:
78 Developing countr
Developing countr
79 ies: dapted from:
ies: dapted from:
80 Schulz KF, Schul
Schulz KF, Schul
81 te JM, Berman SM.
te JM, Berman SM.
82 Maternal health
Maternal health
83 and child surviva
and child surviva
84 l: opportunities
l: opportunities
85 to protect both w
to protect both w
86 omen and children
omen and children
87 from the adverse
from the adverse
88 consequences of
consequences of
89 reproductive trac
reproductive trac
90 t infections. In:
t infections. In:
91 Germain A, Holme
Germain A, Holme
92 s KK, Piot P, Was
s KK, Piot P, Was
93 serheit JN, edito
serheit JN, edito
94 rs. Reproductive
rs. Reproductive
95 tract infections:
tract infections:
96 global impact an
global impact an